Annual Accounts Payable
$7.45 M
+$2.30 M+44.59%
December 31, 2023
Summary
- As of February 7, 2025, NTLA annual accounts payable is $7.45 million, with the most recent change of +$2.30 million (+44.59%) on December 31, 2023.
- During the last 3 years, NTLA annual accounts payable has fallen by -$3.01 million (-28.76%).
- NTLA annual accounts payable is now -28.76% below its all-time high of $10.46 million, reached on December 31, 2020.
Performance
NTLA Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$13.14 M
-$5.67 M-30.14%
September 30, 2024
Summary
- As of February 7, 2025, NTLA quarterly accounts payable is $13.14 million, with the most recent change of -$5.67 million (-30.14%) on September 30, 2024.
- Over the past year, NTLA quarterly accounts payable has increased by +$9.59 million (+269.97%).
- NTLA quarterly accounts payable is now -30.14% below its all-time high of $18.82 million, reached on June 30, 2024.
Performance
NTLA Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
NTLA Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +44.6% | +270.0% |
| 3 y3 years | -28.8% | +76.0% |
| 5 y5 years | +175.2% | +189.0% |
NTLA Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -22.8% | +44.6% | -30.1% | +270.0% |
| 5 y | 5-year | -28.8% | +89.1% | -30.1% | >+9999.0% |
| alltime | all time | -28.8% | +3644.7% | -30.1% | >+9999.0% |
Intellia Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $13.14 M(-30.1%) |
| Jun 2024 | - | $18.82 M(+37.5%) |
| Mar 2024 | - | $13.69 M(+83.7%) |
| Dec 2023 | $7.45 M(+44.6%) | $7.45 M(+109.7%) |
| Sep 2023 | - | $3.55 M(-69.5%) |
| Jun 2023 | - | $11.63 M(+68.9%) |
| Mar 2023 | - | $6.89 M(+33.7%) |
| Dec 2022 | $5.15 M(-46.6%) | $5.15 M(+17.6%) |
| Sep 2022 | - | $4.38 M(-41.7%) |
| Jun 2022 | - | $7.51 M(-25.9%) |
| Mar 2022 | - | $10.14 M(+5.0%) |
| Dec 2021 | $9.65 M(-7.7%) | $9.65 M(+29.2%) |
| Sep 2021 | - | $7.47 M(+9.0%) |
| Jun 2021 | - | $6.85 M(-21.1%) |
| Mar 2021 | - | $8.69 M(-16.9%) |
| Dec 2020 | $10.46 M | $10.46 M(+34.5%) |
| Sep 2020 | - | $7.78 M(>+9900.0%) |
| Jun 2020 | - | $7000.00(-99.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $3.87 M(-1.8%) |
| Dec 2019 | $3.94 M(+45.5%) | $3.94 M(-13.3%) |
| Sep 2019 | - | $4.55 M(+146.1%) |
| Jun 2019 | - | $1.85 M(-49.9%) |
| Mar 2019 | - | $3.69 M(+36.2%) |
| Dec 2018 | $2.71 M(+24.7%) | $2.71 M(+54.4%) |
| Sep 2018 | - | $1.75 M(+423.6%) |
| Jun 2018 | - | $335.00 K(-82.5%) |
| Mar 2018 | - | $1.92 M(-11.8%) |
| Dec 2017 | $2.17 M(-53.3%) | $2.17 M(-1.0%) |
| Sep 2017 | - | $2.19 M(-3.2%) |
| Jun 2017 | - | $2.27 M(+58.1%) |
| Mar 2017 | - | $1.43 M(-69.2%) |
| Dec 2016 | $4.65 M(+242.1%) | $4.65 M(+608.1%) |
| Sep 2016 | - | $657.00 K(-36.9%) |
| Jun 2016 | - | $1.04 M(-13.6%) |
| Mar 2016 | - | $1.21 M(-11.3%) |
| Dec 2015 | $1.36 M(+583.4%) | $1.36 M |
| Dec 2014 | $199.00 K | - |
FAQ
- What is Intellia Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Intellia Therapeutics?
- What is Intellia Therapeutics annual accounts payable year-on-year change?
- What is Intellia Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Intellia Therapeutics?
- What is Intellia Therapeutics quarterly accounts payable year-on-year change?
What is Intellia Therapeutics annual accounts payable?
The current annual accounts payable of NTLA is $7.45 M
What is the all time high annual accounts payable for Intellia Therapeutics?
Intellia Therapeutics all-time high annual accounts payable is $10.46 M
What is Intellia Therapeutics annual accounts payable year-on-year change?
Over the past year, NTLA annual accounts payable has changed by +$2.30 M (+44.59%)
What is Intellia Therapeutics quarterly accounts payable?
The current quarterly accounts payable of NTLA is $13.14 M
What is the all time high quarterly accounts payable for Intellia Therapeutics?
Intellia Therapeutics all-time high quarterly accounts payable is $18.82 M
What is Intellia Therapeutics quarterly accounts payable year-on-year change?
Over the past year, NTLA quarterly accounts payable has changed by +$9.59 M (+269.97%)